Records containing: Stage II Ovarian Cancer AJCC v6 and v7

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-07
Blinded Reference Set for Multicancer Early Detection Blood Tests
CLINICAL_TRIALS study record update · 2021-09-30
Chemotherapy Toxicity in Elderly Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
CLINICAL_TRIALS study record update · 2021-04-19
Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study
CLINICAL_TRIALS study record update · 2020-08-10
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
CLINICAL_TRIALS study record update · 2019-08-29
Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2019-03-12
Quality of Life and Care Needs in Patients With Persistent or Recurrent Platinum-Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
CLINICAL_TRIALS study record update · 2018-05-18
A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
CLINICAL_TRIALS study record update · 2018-05-18
A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma